Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for AVY given its capital-intensive manufacturing base, acquisitive growth strategy, and shareholder-return commitments that require both earnings capacity and balance-sheet flexibility.

Composite Trajectory: Mixed

Annual results show a stable-to-slightly-improving earnings trend (diluted EPS rose to $8.79 in FY2025 from $8.73 in FY2024 despite a $17M decline in net income) but a deteriorating balance sheet (total debt rose 18% to $3.73B while equity fell 3% to $2.24B). Quarterly trends through H1 2026 are strongly improving across all three statements: six-month revenue grew 9% to $4.76B, net income rose 5% to $372M, operating cash flow surged to $545M from $193M, and debt declined slightly to $3.68B while equity rose to $2.32B. The divergence between annual leverage expansion and recent quarterly deleveraging drives the mixed assessment.

2. Red Flags

• Annual operating cash flow fell 6% to $881M in FY2025 while net income fell only 2% to $688M, with the filing citing higher incentive compensation, tax payments, and trade rebates as drivers (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Share repurchases more than doubled to $572M in FY2025 from $248M in FY2024 despite the operating cash flow decline, funded partly by a €500M senior note issuance (10-K 2025-12-31, Consolidated Statements of Cash Flows; Note 4).
• Total debt increased 18% year-over-year to $3.73B at December 31, 2025 while shareholders' equity declined 3% to $2.24B, raising the debt-to-equity ratio (10-K 2025-12-31, Consolidated Balance Sheets).
• Restructuring charges have been recorded in three consecutive annual periods: $48.8M (2025 actions) in FY2025, $28.8M (2023 actions) in FY2024, and $34.7M (2026 actions) in H1 2026, suggesting a recurring pattern despite being labeled as discrete actions (10-K 2025-12-31, MD&A Cost Reduction Actions; 10-Q 2026-06-30, MD&A Cost Reduction Actions).
• Interest expense rose 16% to $135.4M in FY2025 and 10% to $71.5M in H1 2026, driven by the September 2025 and November 2024 euro note issuances (10-K 2025-12-31, MD&A Interest Expense; 10-Q 2026-06-30, MD&A Interest Expense).
• Effective tax rate increased to 28.8% in H1 2026 from 26.4% in H1 2025, and to 27.8% in Q2 2026 from 26.0% in Q2 2025, due to discrete tax reserve increases (10-Q 2026-06-30, MD&A Provision for Income Taxes).
• Operational working capital as a percentage of annualized quarterly sales worsened to 13.4% in FY2025 from 12.6% in FY2024 (10-K 2025-12-31, Financial Condition Analysis of Selected Financial Ratios).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP net income dipped to $688M in FY2025 from $705M in FY2024, but diluted EPS rose to $8.79 from $8.73 due to a 2.8% reduction in weighted-average diluted shares (10-K 2025-12-31, Consolidated Statements of Income). Revenue grew 1% to $8.86B, gross profit rose 1% to $2.55B (28.8% margin vs 28.9%), and marketing, general & administrative expense increased 0.5% to $1.42B. Income before taxes fell 3% to $925M as interest expense climbed 16% to $135M. In contrast, H1 2026 showed clear improvement: six-month revenue rose 9% to $4.76B, gross profit increased 11% to $1.39B (29.3% margin vs 28.9%), net income grew 5% to $372M, and diluted EPS rose 8% to $4.85 (10-Q 2026-06-30, Consolidated Statements of Operations). Segment trends diverged: Materials Group organic sales declined 1% in FY2025 but grew 6% in H1 2026; Solutions Group organic sales grew 2% in FY2025 and 1% in H1 2026 (10-K 2025-12-31, Results of Operations by Reportable Segment; 10-Q 2026-06-30, Results of Operations by Reportable Segment).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow declined to $881M in FY2025 from $939M in FY2024, though it remained above the $826M in FY2023. Capital expenditures continued a three-year downtrend to $169M from $209M and $265M, keeping simple free cash flow (operating less CapEx) roughly flat at $712M vs $730M. Adjusted free cash flow (non-GAAP) edged up to $707M from $700M (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Cash Flow). Investing cash flow swung to a $596M outflow in FY2025 from $243M in FY2024, driven by the $390M Taylor Adhesives acquisition. H1 2026 showed a dramatic rebound: operating cash flow jumped to $545M from $193M in H1 2025 (which was depressed by working capital changes), and adjusted free cash flow rose to $470M from $136M (10-Q 2026-06-30, Consolidated Statements of Cash Flows; MD&A Cash Flow). The H1 2026 improvement appears partially due to easier comparables rather than a structural shift.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

The annual comparison shows deterioration: cash fell 38% to $203M at December 31, 2025 from $329M a year earlier; total debt rose 18% to $3.73B from $3.15B (short-term borrowings down 12% to $523M but long-term debt up 25% to $3.21B following the €500M September 2025 note issuance); shareholders' equity declined 3% to $2.24B as $572M in share repurchases and $288M in dividends exceeded $688M net income (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Shareholders' Equity). Goodwill and intangibles increased 15% and 10% respectively from the Taylor Adhesives acquisition. The quarterly comparison through June 30, 2026 shows improvement: cash recovered to $227M, total debt declined slightly to $3.68B, accounts payable rose 21% to $1.52B (extending days payable to 80 from 75), and equity grew 3.6% to $2.32B as H1 net income and positive OCI exceeded shareholder distributions (10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

• Q1 2026 vs Q1 2025 income statement, cash flow, and balance sheet details (10-Q 2026-03-31 filing listed but full XBRL not provided in the document set)
• Q3 2025 vs Q3 2024 comparative figures for sequential quarterly trend analysis (10-Q 2025-09-27 filing listed but full XBRL not provided)
• Full quarterly series for 2025 and 2026 to assess sequential (QoQ) trends within each fiscal year
• Segment-level cash flow and balance sheet data (filings state segment assets are not internally generated or reviewed)
• Detailed breakdown of "Other expense (income), net" components for all quarterly periods to assess recurring vs non-recurring nature
• Reconciliation of non-GAAP adjusted free cash flow to GAAP operating cash flow for quarterly periods beyond H1 2026